Mirati.com

Mirati.com has server used 209.50.49.99 (United States) ping response time Hosted in UpCloud USA Inc Register Domain Names at easyDNS Technologies Inc.. This domain has been created 18 years, 224 days ago, remaining 3 years, 141 days. You can check the 9 Websites and blacklist ip address on this server

Domain information

Registrar WHOIS Server: whois.easydns.com

Registrar URL: http://www.easydns.com     See All 7,281+

Creation Date: 2002-12-14 18 years, 224 days

Updated Date: 2019-12-10 1 year, 229 days ago

Expiry Date: 2024-12-14 3 years, 141 days left     See All

  Sign up for notifications near expiration

Registrar: easyDNS Technologies Inc.

Abuse Email: n/a

Abuse Phone: n/a

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email
www.godaddy.com2,280,668GoDaddy.com, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a PublicDomainRegistry.com[email protected]
www.whois.godaddy.com174,077GoDaddy.com, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions

  › Mirati

  › Mirati therapeutics

  › Mirati kras

  › Mirati trial

  › Mirati mrtx1133

  › Miratix

  › Miraticy

  › Miratite

  › Miratiz

  › Miration

  › Mirative

  › Mirati tx

  › Mirati ir

  › Mirati 10k

  › Mirati 516

  › Mirati ceo

  › Mirati cfo

  › Mirati ipo

  › Mirati stock

  › Mirati therapeutics stock

  › Mirati stock price

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

› Mirati kras g12c

› Mirati stock price

› Mirati therapeutics news

› Mirati therapeutics inc

› Mirati g12c

› Mirati pipeline

› Mirati stock

› Mirati therapeutics

Hosting Provider

NetName: UU-7

Organization: UpCloud USA Inc     See All 1,314+

Provider URL: Upcloud.com

Hostname: albus.wordkeeper.net

IP Server: 209.50.49.99 Reg: 2016-01-15, Updated: 2016-01-15

Blacklist: Check Backlist Status

Country: United States

Address: Four Embarcadero Center, San Francisco, CA 94111, US

Latitude: 37.798901

Longitude: -122.398399

Name Server:

  • DNS1.EASYDNS.COM
  • DNS2.EASYDNS.NET
  • DNS3.EASYDNS.CA

Abuse Email: [email protected]

Abuse Phone: +1-888-447-8860

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,706GoDaddy.com, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

  1: [email protected]

  2: [email protected]

  3: [email protected]

  4: [email protected]

Find Websites hosted

1: Mirati.com

2: Ir.mirati.com Changed to: 162.159.130.11

3: Visionlife.org

4: Breakfastcure.com

5: Rubiconlodi.com

6: Magneticsprings.com

7: Westmountrc.com

8: Brientip.com

9: Occasionography.com

At least 9 Sites on this server

Port Scanner (IP: 209.50.49.99)

Mirati Therapeutics, Inc. Profile

  • Mailing Address: 9393 Towne Centre Drive, Suite 200 San Diego, California 92121: Head Office Address: 9393 Towne Centre Drive, Suite 200 San Diego, California 92121: Contact Name: Vickie Reed: Principal Regulator: Quebec: Business e-mail address: [email protected]: Short Form Prospectus Issuer: No: Telephone Number: 858

Sedar.com   DA: 9 PA: 18 MOZ Rank: 27

Mirati Virtual Social Media Management Email Marketing

  • I created Mirati Virtual as a way to provide consumer packaged brands support in finding their audiences online and amplifying their message
  • We make it easy for businesses to grow their traffic and sales by developing a powerful brand voice on social media and integrating email marketing that relates to the unique buying journey each customer

Mirativirtual.com   DA: 17 PA: 17 MOZ Rank: 35

Twinbeech Capital LP Sells 5,986 Shares Of Mirati

  • Twinbeech Capital LP decreased its stake in Mirati Therapeutics, Inc
  • (NASDAQ:MRTX) by 77.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC)
  • The fund owned 1,780 shares of the biotechnology company’s stock after selling 5,986 shares during the period
  • Twinbeech Capital LP’s holdings in Mirati Therapeutics were […]

Mayfieldrecorder.com   DA: 20 PA: 50 MOZ Rank: 72

Mirati Therapeutics And Zai Lab Enter Into A Collaboration

  • Investor Relations: Temre Johnson | 858-332-3562 | [email protected] Media Relations: Priyanka Shah | 908-447-6134 | [email …

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 71

Senior Scientist, Medicinal Chemistry 2021-243

  • Email Me Similar Jobs Email Me This Job
  • Mirati Therapeutics (NASDAQ: MRTX) is a San Diego-based late -stage biotechnology company relentlessly focused on translating drug discovery and research into new treatments for patients by advancing and delivering novel therapeutics that target the genetic and immunologic drivers of cancer.

Applicantpro.com   DA: 20 PA: 50 MOZ Rank: 74

Mirati Therapeutics Announces Closing Of Public Offering

  • (Nasdaq: MRTX) today announced the closing of its previously announced underwritten public offering of 4,985,706 shares of …

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 72

Mirati Cancer Drug Results Spark Hopes Of Outperforming

Dive Brief: Mirati Therapeutics' experimental cancer drug adagrasib helped shrink tumors in 45% of patients with relapsed lung cancer in a small trial, according to Phase 1/2 study data released Sunday, raising hopes the pill may outperform Amgen's more-advanced competitor, sotorasib.; Seven of 14 patients in the Phase 1 portion of the trial were still on treatment after more than six months

Biopharmadive.com   DA: 21 PA: 50 MOZ Rank: 77

BOEHRINGER INGELHEIM AND MIRATI THERAPEUTICS …

  • INGELHEIM, GERMANY AND SAN DIEGO, CA – September 17, 2020 – Boehringer Ingelheim and Mirati Therapeutics, Inc
  • (NASDAQ: MRTX) today announced a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor blocking KRAS independent of mutation type, and MRTX849, a KRAS G12C selective inhibitor in patients with solid tumors that …

Boehringer-ingelheim.us   DA: 27 PA: 50 MOZ Rank: 84

IT Support And Systems Analyst 2021-303

  • Email Me Similar Jobs Email Me This Job
  • Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones
  • The company is relentlessly focused on bringing forward therapies that

Applicantpro.com   DA: 20 PA: 50 MOZ Rank: 78

Structural Biology Intern 2021-C-003

  • Email Me Similar Jobs Email Me This Job
  • The Drug Discovery team at Mirati is responsible for the invention, optimization, and characterization of small molecules as clinical candidates for the Mirati research portfolio
  • Mirati is seeking an intern with an interest in Structural Biology to join the Drug Discovery group.

Applicantpro.com   DA: 20 PA: 50 MOZ Rank: 79

Mirati Therapeutics' Adagrasib Receives Breakthrough

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 77

Director Of Supply Chain Planning 2021-030

Email Me Similar Jobs Email Me This Job Job Description Summary We are looking for an experienced Director of Supply Chain Planning to lead all clinical and commercial supply planning activities across Mirati's global supply chain network to support our rapidly expanding clinical pipeline and to prepare for the launch of multiple commercial

Applicantpro.com   DA: 20 PA: 50 MOZ Rank: 81

Clinical Collaboration For KRAS-Inhibitor Press

  • INGELHEIM, GERMANY AND SAN DIEGO, CA – 17 September 2020 – Boehringer Ingelheim and Mirati Therapeutics, Inc
  • (NASDAQ: MRTX) today announced a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor blocking KRAS independent of mutation type, and MRTX849, a KRAS G12C selective inhibitor in patients with solid tumors that …

Boehringer-ingelheim.com   DA: 28 PA: 46 MOZ Rank: 86

Chemistry Intern 2021-C-002 Job In San Diego, CA At Mirati

  • Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones
  • The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a

Ziprecruiter.com   DA: 20 PA: 50 MOZ Rank: 83

Mirati's (MRTX) Adagrasib Gets Breakthrough Therapy Status

  • MRTX announced that adagrasib — an investigational, highly selective, and potent oral small-molecule inhibitor of KRAS G12C …

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 78

Manager, Research Networks, Study Start-up 2021-152 Job In

Mirati is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine

Ziprecruiter.com   DA: 20 PA: 50 MOZ Rank: 85

Structural Biology Intern 2021-C-003 Job In San Diego, CA

  • Mirati Therapeutics is a late-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones
  • The company is relentlessly focused on bringing forward therapies that address areas of high unmet need, including lung

Ziprecruiter.com   DA: 20 PA: 50 MOZ Rank: 86

Mirati Therapeutics' Adagrasib Receives Breakthrough

  • Mirati Therapeutics' Adagrasib Receives Breakthrough Therapy Designation from U.S
  • Food and Drug Administration for Patients with Advanced Non-Small Cell Lung Cancer Harboring the KRAS G12C Mutation

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 85

Mirati Therapeutics' Adagrasib Receives Breakthrough

  • SAN DIEGO, June 24, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc
  • (NASDAQ: MRTX), a clinical-stage targeted oncology company, announced today that the U.S
  • Food and Drug Administration (FDA) has

Wfmz.com   DA: 12 PA: 50 MOZ Rank: 80

Mirati Therapeutics, Inc. (NASDAQ:MRTX) Expected To

  • Analysts expect Mirati Therapeutics, Inc
  • (NASDAQ:MRTX) to post ($2.41) earnings per share for the current fiscal quarter, Zacks Investment Research reports
  • Zero analysts have made estimates for Mirati Therapeutics’ earnings, with the lowest EPS estimate coming in at ($2.72) and the highest estimate coming in at ($1.55)
  • Mirati Therapeutics posted earnings of ($1.89) per share […]

Mayfieldrecorder.com   DA: 20 PA: 50 MOZ Rank: 89

Recently Analyzed

1: Marusan-web.com 3 seconds ago

2: Timecapital.com 1 seconds ago

3: Perceptumlimited.com 2 seconds ago

4: Scanntech.com 0 seconds ago

5: Johnbrooksrealty.com 0 seconds ago

6: Dcicristalnet.com 1 seconds ago

7: Paranaquechamber.com 1 seconds ago

8: Saisiddhii.com 0 seconds ago

9: Schiff-law.com 1 seconds ago

10: Segafan.com 1 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Segafan.com 67 days leftNameCheap, Inc.GoDaddy.com, LLC
Schiff-law.com4 years, 232 days leftNetwork Solutions, LLCGoogle LLC
Saisiddhii.com 271 days leftGoDaddy.com, LLCGoogle LLC
Paranaquechamber.com 229 days leftTucows Domains Inc.The Endurance International Group, Inc.
Dcicristalnet.com 29 days leftGoDaddy.com, LLCMicrosoft Corporation
Johnbrooksrealty.com 339 days leftNameCheap, Inc.Namecheap, Inc.
Scanntech.com5 years, 159 days leftWild West Domains, LLC
Perceptumlimited.com 263 days lefteNom, LLCDomain Name Services
Timecapital.com2 years, 46 days leftNetwork Solutions, LLCAmazon Technologies Inc.
Marusan-web.com 190 days leftGMO Internet, Inc. d/b/a Onamae.comASAHI Net,Inc.

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]